Survey: 4-in-5 moms turn to OTC option to treat head lice
SWIFTWATER, Pa. — A new national survey released Wednesday found that the majority of moms who have experienced head lice in their household as an adult (81%) used an OTC treatment the last time they had an infestation. Less than a third of moms (27%) chose a prescription option.
The online survey was conducted by Harris Poll on behalf of Sanofi Pasteur during back-to-school season, among more than 2,000 U.S. moms aged 25 and older. Moms define the ideal head lice treatment as one that works quickly (78%), is safe (76%) and is easy to use (74%). Approximately 67% of moms are aware of prescription treatments and 80% are aware of over-the-counter treatments. Only 32% of moms who used an OTC treatment the last time they or a member of their household had head lice say the infestation was eliminated with just one treatment; the remainder (68%) say they used two or more OTC applications to treat the infestation or report the treatment did not resolve the infestation.
The Centers for Disease Control and Prevention advises that the removal of all nits after successful treatment is not necessary and there are numerous treatment options with a range of application directions and safety profiles.
However, most moms believe that in order to get rid of an infestation you have to comb out the nits (88% of all moms and 90% of those with experience as an adult) and more than half (55% of all moms and 54% of those with experience as an adult) think that all head lice treatments require multiple applications.
Findings also demonstrate that more than three-in-four moms (77% of all moms and 89% of those with experience as an adult) believe that they know where to find reliable information about head lice — 17% turned first to a doctor, nurse or other healthcare provider and 19% turned first to a pharmacist for treatment advice the last time they had an infestation in their household.
UrgentRx partners with Denver-area sports franchises to be ‘Official Sponsor of Game Day Relief’
DENVER — UrgentRx on Tuesday teamed up with the NFL’s Denver Broncos, the NBA’s Indiana Pacers and Kroenke Sports & Entertainment — parent of NBA’s Denver Nuggets, NHL’s Colorado Avalanche and NLL’s Colorado Mammoth — to be the “Official Sponsor of Game Day Relief.”
“Headaches, upset stomach, allergies and other common ailments often strike when you’re away from your medicine cabinet — including when you just want to enjoy the game,” said Jordan Eisenberg, president UrgentRx. “Our partnerships with these great professional sports organizations puts UrgentRx Fast Powders within reach of sports fans, so they don’t have to worry about missing that crucial shot or the game-winning goal.”
As the “Official Sponsor of Game Day Relief,” UrgentRx is delivering its over-the-counter powdered medications via various game-day promotions and in-stadium sales at Pepsi Center, Mile High Stadium and Bankers Life Fieldhouse from stadium bathroom take-overs to “lucky row” game-day relief giveaways.
CHPA: More consumers more aware of APAP overdose concerns
WASHINGTON — New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage. A nationwide consumer survey conducted by the Consumer Healthcare Products Association Educational Foundation, in conjunction with its work on the Acetaminophen Awareness Coalition’s Know Your Dose educational campaign, shows that consumer safe use knowledge and risk awareness has increased over a three year period (2010-2013).
“More than 50 million people use medicines containing acetaminophen each week to relieve pain. We are very encouraged to see more consumers today know how and why to follow the label and dosing directions when taking acetaminophen to ensure safe and appropriate use,” stated Emily Skor, executive director of the CHPA Educational Foundation. “These research findings validate the importance of our ongoing consumer education initiatives. They will continue to serve as a benchmark for educational efforts as we find new ways to engage and educate consumers about the safe use of medicines.”
“Awareness is a critical step toward behavior change. These strides in consumer knowledge about the safe use of pain relievers and acetaminophen specifically are gratifying, and reinforce the need for continued education to ensure that knowledge translates into a reduction in acetaminophen-related liver damage,” added Anne Norman, a family nurse practitioner and associate VP of education at the American Association of Nurse Practitioners. “In my own practice, I’ve seen patients unknowingly take more than one medicine containing acetaminophen at the same time and exceed the recommended daily dose. That’s why ongoing education is so important — via healthcare providers, via pharmacists, via media and other channels. Reaching consumers at key points of relevancy and impact remain important as we continue to work together to drive safe medicine use.”
Acetaminophen is found in more than 600 prescription and over-the-counter pain relievers, fever reducers and sleep aids as well as cough, cold, and allergy medicines. Acetaminophen is safe and effective when used as directed but there is a limit to how much can be taken in one day. The U.S. Food and Drug Administration recommends taking no more than 4,000 mg of acetaminophen in a 24-hour period. Taking more than directed is an overdose and can lead to liver damage.
Findings from the national survey of 1,000 consumers who have taken a pain reliever in the past 6-12 months show enhanced consumer knowledge and awareness of key medicine safety issues:
- Label reading: More consumers agree that it is “important to check the label to find out the maximum daily dose” of medicines (increased to 98% in 2013 from 93% in 2010);
- Following dosing instructions: More consumers agree it is “important not to exceed the dosing directions on the label” of pain relievers (increased to 96% in 2013 from 90% in 2010);
- Awareness of risk: More consumers understand that “exceeding the recommended daily dose of acetaminophen may lead to liver damage” (increased to 87% in 2013 from 78% in 2010); and
- Avoidance of “doubling up:” Knowledge that “acetaminophen can be found in many over-the-counter and prescription pain medicines” (increased to 87% from 80% in 2010) andu nderstanding that “it is possible to exceed the maximum daily dose when taking an OTC acetaminophen product at the same time as a prescription pain medicine” (increased to 81% from 76% in 2010).